About the Multiple Myeloma March
Walk the Walk. Make Myeloma Matter.
Welcome to Myeloma Canada’s 14th Annual Multiple Myeloma March!
In light of COVID-19, some cities may be modifying the format of their March. Please be sure to check your city’s March page often. Click here to find your city.
Myeloma Canada’s Multiple Myeloma March is our most important fundraising event, enabling us to raise money for critical research and move one step closer to a cure. This year has been a challenging one, and physical distancing has affected many in-person activities, but we’re not letting that stop us! We’re committed as ever to reaching our goal of raising $600,000 to fund research that is meaningful to you!
It's your March, your way!
Back for its 2nd year…the Personalized Distance Challenge! Set your own personal goal (to run, walk, cycle) starting on the day you register until the day of your community Multiple Myeloma March. It’s a great way to stay healthy, active and energized throughout the months leading up to your event. Find out more here.
Your support of the 2022 Multiple Myeloma March is absolutely crucial…this is our most important campaign year and we can’t do it without you.
Register for one of more than 32 participating communities, or if there isn’t a March close to you, join our ‘Virtual” March Team. Help us take one step closer to finding a cure.
Funds raised through this year’s Multiple Myeloma March will go toward furthering important research projects you’ve identified as a priority to you through the PSP. Learn more here.
We’ll also continue to fund the Canadian Myeloma Research Group (CMRG) in their advancement of Canadian clinical trials in myeloma, as well as real world evidence generation using their national myeloma database.
If you have any questions about the Multiple Myeloma March, or would like to start one in your community, please contact Michelle Oana, Director of Development and Community Relations at firstname.lastname@example.org or by telephone at 514 421‑2242 (toll-free: 1-888 798‑5771).